Perturbation of NCOA6 leads to dilated cardiomyopathy

Jae-Il Roh1, Cheolho Cheong2, Young Hoon Sung1

  • 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea.

Cell Reports
|August 19, 2014
PubMed

Insights

Mutations in the NCOA6 gene are linked to dilated cardiomyopathy (DCM), a serious heart condition. This discovery offers new insights into the genetic causes of DCM in adults.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Human Disease Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a progressive heart condition marked by left ventricular enlargement and impaired contractility.
  • While mouse models have identified candidate genes, their direct link to human DCM remains limited.
  • Nuclear hormone receptor coactivator 6 (NCOA6) deficiency causes embryonic lethality and heart defects, but its role in adult heart disease is unknown.

Purpose of the Study:

  • To investigate the role of NCOA6 dysfunction in adult dilated cardiomyopathy.
  • To determine if mutations in NCOA6 are associated with idiopathic DCM (iDCM) in human patients.

Main Methods:

  • Generated and analyzed two independent mouse models with NCOA6 dysfunction.
  • Assessed cardiac function, mitochondrial function, and peroxisome proliferator-activated receptor delta (PPARδ) activity in mouse models.
  • Sequenced NCOA6-coding regions in patients diagnosed with idiopathic DCM.

Main Results:

  • Mouse models of NCOA6 dysfunction exhibited severe DCM, impaired mitochondrial function, and reduced PPARδ activity.
  • Three distinct nonsynonymous NCOA6 mutations were identified in 5 out of 50 (10%) iDCM patients.
  • NCOA6 is a critical target for PPARδ, which is essential for normal heart function.

Conclusions:

  • NCOA6 dysfunction can lead to severe dilated cardiomyopathy in mouse models.
  • NCOA6 mutations are present in a subset of patients with idiopathic DCM, suggesting a causal link.
  • NCOA6 plays a crucial role in maintaining adult heart function, potentially through its regulation of PPARδ.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
785
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
934
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
811
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
477
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
643